Wealth Management Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,725
| Closed | -$263K | – | 205 |
|
|
2023
Q4 | $263K | Hold |
2,725
| – | – | 0.14% | 157 |
|
|
2023
Q3 | $241K | Buy |
2,725
+285
| +12% | +$25.2K | 0.14% | 154 |
|
|
2023
Q2 | $211K | Sell |
2,440
-182
| -7% | -$15.8K | 0.12% | 174 |
|
|
2023
Q1 | $255K | Sell |
2,622
-706
| -21% | -$68.7K | 0.16% | 152 |
|
|
2022
Q4 | $344K | Sell |
3,328
-1,789
| -35% | -$185K | 0.23% | 102 |
|
|
2022
Q3 | $434K | Hold |
5,117
| – | – | 0.31% | 90 |
|
|
2022
Q2 | $424K | Hold |
5,117
| – | – | 0.29% | 88 |
|
|
2022
Q1 | $395K | Hold |
5,117
| – | – | 0.22% | 116 |
|
|
2021
Q4 | $452K | Buy |
5,117
+1,691
| +49% | +$149K | 0.24% | 109 |
|
|
2021
Q3 | $265K | Buy |
3,426
+902
| +36% | +$69.7K | 0.15% | 150 |
|
|
2021
Q2 | $211K | Buy |
+2,524
| New | +$211K | 0.12% | 188 |
|